Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis

Hypersensitivity pneumonitis (HP) is an immunologically mediated form of lung disease resulting from inhalational exposure to any of a large variety of antigens. A subgroup of patients with HP develops pulmonary fibrosis (fibrotic HP; FHP), a significant cause of morbidity and mortality. This study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ERJ Open Res
Autori principali: Fernández Pérez, Evans R., Crooks, James L., Swigris, Jeffrey J., Solomon, Joshua J., Mohning, Michael P., Huie, Tristan J., Koslow, Matthew, Lynch, David A., Groshong, Steve D., Fier, Kaitlin
Natura: Artigo
Lingua:Inglês
Pubblicazione: European Respiratory Society 2021
Soggetti:
Study Protocols
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181708/
https://ncbi.nlm.nih.gov/pubmed/34109243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00054-2021
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi